Journal Report

Klinicka Onkologie

Download PDF
Journal Information
Journal Title
Klinicka Onkologie
Publisher
Czech Medical Association J.E. Purkyne
ISSN
0862-495X
E-ISSN
1802-5307
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓
2025 ✓
2024 ✓
2023 ✓
2021/2022 ✓
2020 ✓
2019 ✓
2018
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
With the exception of perinephritic fluid collection, all symptoms of TEMPI syndrome resolved following treatment for Waldenström macroglobulinemia
Zdeněk Adam, Jiří Vaníček, Zdeněk Řehák et al.
2026-10-15 Vol. 39 Issue 5 Pages 344-355
DOI: 10.48095/ccko2026344
Long term response to immunotherapy in a patient with low PD-L1 expression, high tumor mutational burden, and STK11 mutation
Michal Kysela, Ondřej Bílek, Radka Lordick Obermannová et al.
2026-10-15 Vol. 39 Issue 5 Pages 364-367
DOI: 10.48095/ccko2026364
FLAURA2 – a step forward in first-line treatment of advanced EGFR-mutated non-small cell lung cancer
Ján Podhorec, Alexandr Poprach
2026-10-15 Vol. 39 Issue 5 Pages 325-330
DOI: 10.48095/ccko2026325
Detection of RET fusion in late-line treatment of NSCLC followed by long-term disease control with selpercatinib
Miriam Šuranová, Ondřej Bílek, Aleš Neumann et al.
2026-10-15 Vol. 39 Issue 5 Pages 368-371
DOI: 10.48095/ccko2026368
Ivosidenib in the treatment of IDH1-mutated cholangiocarcinoma – a review of current evidence and case report demonstrating durable disease control
Michal Eid, Ľudmila Eidová
2026-10-15 Vol. 39 Issue 5 Pages 356-363
DOI: 10.48095/ccko2026356
Graft versus host disease as a marker for assessing quality of life in patients after allogeneic hematopoietic cell transplantation - results of a retrospective study
Simona Pavúková, Roman Králik, Dana Dudová et al.
2026-10-15 Vol. 39 Issue 5 Pages 331-336
DOI: 10.48095/ccko2026331
Prediction of residual disease after chemotherapy in advanced NSGCT – does microRNA provide clinical benefits?
Tomáš Pokrivčák, Roman Hrstka, Jan Švancara et al.
2026-10-15 Vol. 39 Issue 5 Pages 337-343
DOI: 10.48095/ccko2026337
Pregnancy-associated EGFR-mutant lung adenocarcinoma in a TB-endemic region – diagnostic bias and therapeutic barriers
Muhammad Hafiz, Aziza G. Icksan, Sita Laksmi Andarini et al.
2026-10-15 Vol. 39 Issue 5 Pages 372-377
DOI: 10.48095/ccko2026372
Can a negative PSMA PET/CT limit the indication for lymphadenectomy in patients with localized moderate- and high-risk prostate cancer?
Kristýna Dianová, Vladimír Šámal, Vít Paldus
2026-10-15 Vol. 39 Issue 5 Pages 320-324
DOI: 10.48095/ccko2026320
Nicotine products on the market and cancer risk
Alexandra Pánková, Kamila Zvolská, Eva Králíková
2026-8-24 Vol. 39 Issue Suppl1 Pages S31-S35
DOI: 10.48095/ccko2026s31
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 6, 2026 18:21